Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Correlation of New Method for Measuring Plasma Myeloperoxidase with Clinical Behavior in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Adam Abdool, Xiugiang Wang, Iman Jilani, Ph.D., Weidong Zhou, M.D., Hagop Kantargian, M.D., Elihu Estey, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 4321.

https://doi.org/10.1182/blood.V110.11.4321.4321

Published: 2007

Journal Articles

Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.

Wanlong Ma, Iman Jilani, Ph.D., Benjamin Bekele, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Zhong Zhang, M.D., Susan O’Brien, M.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2837.

https://doi.org/10.1182/blood.V110.11.2837.2837

Published: 2007

Journal Articles

Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications.

Wanlong Ma, Xi Zhang, Iman Jilani, Ph.D., Farhad Ravandi, Elihu Estey, M.D., Hagop Kantarjian, M.D., Francis Giles, M.D., Mohammad Sheikholeslami, M.D., Michael Keating, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2855.

https://doi.org/10.1182/blood.V110.11.2855.2855

Published: 2007

Journal Articles

Intensively Timed Induction (ITI) Chemotherapy in Adults with Acute Myelogenous Leukemia (AML).

Michael Rytting, MD, Srdan Verstovsek, M.D., Ph.D., Guillermo Garcia-Manero, M.D., Farhad Ravandi-Kashani, M.D., Sherry Pierce, R.N., Elihu Estey, M.D.

Blood (2007) 110 (11): 1851.

https://doi.org/10.1182/blood.V110.11.1851.1851

Published: 2007

Journal Articles

Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Susan O’Brien, M.D., Iman Jilani, Ph.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 4546.

https://doi.org/10.1182/blood.V110.11.4546.4546

Published: 2007

Journal Articles

Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.

Michael Andreeff, MD, PhD, Sergej Konoplev, M.D., Ph.D., Rui-Yu Wang, M.D., Ph.D., Zhihong Zeng, Ph.D., Teresa McQueen, Yue-Xi Shi, L. Jeffrey Medeiros, M.D., Elihu Estey, M.D., John M. McCarty, M.D., Stephanie Elkins, M.D., Richard Champlin, M.D., Gary Calandra, M.D., Ph.D., Gary Bridger, Ph.D., Marina Konopleva, M.D., Ph.D.

Blood (2006) 108 (11): 568.

https://doi.org/10.1182/blood.V108.11.568.568

Published: 2006

Journal Articles

Clinical Features and Prognosis of Patients with Myelodysplastic/Myeloproliferative Syndrome-Unclassified (MDS/MPD-U): Refractory Anemia with Ringed Sideroblasts with Thrombocytosis (RARS-T) Is a Favorable Prognostic Subgroup.

Ehab Atallah, MD, Hagop Kantarjian, M.D., Jorge Cortes, M.D., Sherry Pierce, R.N., Elihu Estey, M.D., Guillermo Garcia-Manero, M.D., Deborah Thomas, M.D., Farhad Ravandi-Kashani, M.D., Francis Giles, M.D., Srdan Verstovsek, M.D.,; PhD.

Blood (2006) 108 (11): 2612.

https://doi.org/10.1182/blood.V108.11.2612.2612

Published: 2006

Journal Articles

Characteristics and Outcomes of 38 Patients with Acute Myeloid Leukemia Evolving from Previous Well Characterized Myeloproliferative Disorder.

Constantine S. Tam, MD, Francis Giles, M.D., Jorge Cortes, M.D., Guillermo Garcia-Manero, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D.;PhD

Blood (2006) 108 (11): 2705.

https://doi.org/10.1182/blood.V108.11.2705.2705

Published: 2006

Journal Articles

A Phase II Study of Azacitidine (Vidaza™) for Patients with Myelofibrosis (MF).

Alfonso Quintas-Cardama, MD, Hagop Kantarjian, M.D., Guillermo Garcia-Manero, M.D., Deborah Thomas, M.D., STeven Kornblau, M.D., Elihu Estey, M.D., Marilyn Nemri, R.N., Jorge Cortes, M.D., Francis Giles, M.D., Srdan Verstovsek, M.D.;PhD

Blood (2006) 108 (11): 2706.

https://doi.org/10.1182/blood.V108.11.2706.2706

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD4 and CD8 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Adam Abdool, Francis Giles, M.D., Menna Hodge, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Elihu Estey, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 1889.

https://doi.org/10.1182/blood.V108.11.1889.1889

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD34 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, M.D., Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4495.

https://doi.org/10.1182/blood.V108.11.4495.4495

Published: 2006

Journal Articles

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome and Their Value in Predicting Clinical Behavior.

Wanlong Ma, Francis Giles, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, Zeev Estrov, M.D., Elihu Estey, M.D., Alessandra Ferrajoli, M.D., Michael Keating, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4497.

https://doi.org/10.1182/blood.V108.11.4497.4497

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD33 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4502.

https://doi.org/10.1182/blood.V108.11.4502.4502

Published: 2006

Journal Articles

Measurement and Clinical Relevance of Proteasome Enzymatic Activity in Plasma of Patients with Acute Lymphoblastic Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, M.D., Zeev Zestrov, M.D., Elihu Estey, M.D, Alessandra Ferrajoli, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4475.

https://doi.org/10.1182/blood.V108.11.4475.4475

Published: 2006

Journal Articles

Granulocytic Sarcoma (GS) Is Associated with Event-Free Survival Superior to That of Acute Myeloid Leukemia (AML).

Apostolia-Maria Tsimberidou, MD, PhD, Michael J. Keating, M.D., Hagop M. Kantarjian, M.D., Susan O’Brien, M.D., Jorge Cortes, M.D., Charles Koller, M.D., BA, Francis Giles, M.D., Sherry Pierce, BSN, BA, Mark Brandt, Miloslav Beran, M.D., Ph.D., Elihu Estey, M.D.

Blood (2006) 108 (11): 2008.

https://doi.org/10.1182/blood.V108.11.2008.2008

Published: 2006

Journal Articles

Simultaneous Activation of Multiple Signal Transduction Pathways Confers Poor Prognosis in Acute Myelogenous Leukemia.

Steven M. Kornblau, M.D., Matthew Womble, Ellen Jackson, R.N., Weijing Chen, M.S., Elihu Estey, M.D., Michael Andreeff, M.D., Ph.D.

Blood (2004) 104 (11): 2992.

https://doi.org/10.1182/blood.V104.11.2992.2992

Published: 2004

Journal Articles

Intracranial Hemorrhage (ICH) in Patients (pts) with Newly Diagnosed Leukemia: Incidence and Effect on Outcome.

Yasuhiro Oki, M.D., Elias Jabbour, M.D., Hagop Kantarjian, M.D., Elihu Estey, M.D., Jorge E. Cortes, M.D., Stefan Faderl, M.D., Sherry Pierce, RN, BSN, BA, Xian Zhou, MS, BS, B. Nebiyou Bekele, Ph.D., Guillermo Garcia-Manero, M.D.

Blood (2004) 104 (11): 4530.

https://doi.org/10.1182/blood.V104.11.4530.4530

Published: 2004

NARROW

Correlation of New Method for Measuring Plasma Myeloperoxidase with Clinical Behavior in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.

Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications.

Intensively Timed Induction (ITI) Chemotherapy in Adults with Acute Myelogenous Leukemia (AML).

Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.

Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.

Clinical Features and Prognosis of Patients with Myelodysplastic/Myeloproliferative Syndrome-Unclassified (MDS/MPD-U): Refractory Anemia with Ringed Sideroblasts with Thrombocytosis (RARS-T) Is a Favorable Prognostic Subgroup.

Characteristics and Outcomes of 38 Patients with Acute Myeloid Leukemia Evolving from Previous Well Characterized Myeloproliferative Disorder.

A Phase II Study of Azacitidine (Vidaza™) for Patients with Myelofibrosis (MF).

Clinical Significance of Free Circulating CD4 and CD8 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Clinical Significance of Free Circulating CD34 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome and Their Value in Predicting Clinical Behavior.

Clinical Significance of Free Circulating CD33 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Measurement and Clinical Relevance of Proteasome Enzymatic Activity in Plasma of Patients with Acute Lymphoblastic Leukemia.

Granulocytic Sarcoma (GS) Is Associated with Event-Free Survival Superior to That of Acute Myeloid Leukemia (AML).

Simultaneous Activation of Multiple Signal Transduction Pathways Confers Poor Prognosis in Acute Myelogenous Leukemia.

Intracranial Hemorrhage (ICH) in Patients (pts) with Newly Diagnosed Leukemia: Incidence and Effect on Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only